JPRN-UMIN000016102已完成未知
Investigation on the effect of favipiravir in preventing Ebola virus disease and its safety - Prophylactic effect of favipiravir on Ebola virus disease
ational Center for Global Health and Medicine0 个研究点目标入组 25 人开始时间: 2015年1月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Person who conflicts any of the following criteria cannot be enrolled in the study. 1.Person who has a high fever 2.Person who was considered as inadequate for this study by the Case Management Committee.
研究者
相似试验
招募中
3 期
The therapeutic effect of Favipiravir in COVID-19 patientsIRCT20211004052664N1Shahid Beheshti University of Medical Sciences80
招募中
3 期
Evaluation the effects of Favipiravir in COVID-19 patientsCOVID-19 pneumonia.COVID-19, virus identifiedU07.1IRCT20151227025726N14Shahid Beheshti University of Medical Sciences84
招募中
3 期
Effect of Favipiravir on outpatient treatment of Covid-19IRCT20171219037964N3Esfahan University of Medical Sciences70
招募中
3 期
The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19IRCT20200506047323N3Bandare-abbas University of Medical Sciences60
已完成
不适用
The Real-world Clinical Outcomes of Favipiravir Treatment in Mild to Moderate COVID-19 Patients in Single Outpatient Visit Followed by Home Isolation: a Multicenter, case-control StudyTCTR20221113004Chulabhorn Royal Academy1,037